NILEMDOswiss (Bempedoic Acid Tablet) 180mg

Nilemdo (bempedoic acid) 180mg tablets are prescribed for cholesterol management. This statin alternative helps lower LDL cholesterol in adults with primary hyperlipidemia. Suitable for those intolerant to statins. Always consult a healthcare provider before use.

Strength

180mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Daiichi Sankyo Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nilemdo 180mg tablets are used to reduce elevated LDL cholesterol levels in adults with primary hyperlipidemia. It may be prescribed alongside diet and other lipid-lowering therapies. The medication works by inhibiting cholesterol synthesis in the liver. Patients intolerant to statins often consider this option as part of their treatment plan.

Side Effects

Nilemdo 180mg tablets may help lower LDL cholesterol over time with consistent use. Some users report improved lipid profiles after several weeks of therapy. Individual responses vary based on diet, lifestyle, and other health factors. Regular monitoring is typically recommended to assess effectiveness.

Precautions & Warnings

Store Nilemdo 180mg tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your doctor about all medications and supplements you take before starting this treatment. Follow the prescribed regimen and attend scheduled check-ups for optimal results.

Avoid Interactions

Nilemdo 180mg may interact with other cholesterol-lowering drugs or certain medications metabolized by the liver. Alcohol consumption may affect how the body processes this medication. Always disclose your full medication list to your healthcare provider to avoid potential interactions.

Frequently Asked Questions

Bempedoic acid is primarily used to lower LDL cholesterol in adults with primary hyperlipidemia, often as an alternative for those unable to tolerate statins.

Individual responses vary, but noticeable effects on cholesterol levels may take several weeks of consistent use.

This depends on your treatment plan; consult your healthcare provider to determine safe combinations.

No, Nilemdo is a non-statin cholesterol-lowering medication that works differently from statins.

Avoid excessive alcohol and discuss all medications with your doctor to prevent potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.